Radioactive iodine is used in the treatment of hyperthyroidism (an overactive thyroid) since the 1940s. New research has revealed that higher organ-absorbed doses of radioactive iodine contribute to an increased risk of death from solid cancer, including breast cancer.
This study is an extension of one that has followed patients in the United States and the United Kingdom treated for hyperthyroidism for nearly 70 years. Researchers sought to determine the association of doses of radioactive iodine absorbed by organs or tissue with overall and site-specific cancer death. This analysis included 18,805 patients treated with radioactive iodine and with no history of cancer at the time of treatment.
Hyperthyroidism
Hyperthyroidism is a condition in which the thyroid gland makes excessive thyroid hormone. Grave's disease is the most common cause of hyperthyroidism.
Advertisement
‘The study has shown a modest association between radioactive iodine treatment for overactive thyroid and the risk of death from cancer among the patients.’
Tweet it Now
The study has limitations, including uncertainties in the organ dose estimates and a limited ability to detect significant associations for some outcomes because of a small number of cancer deaths and relatively small doses of radioactive iodine to organs other than the thyroid. More studies are needed to compare the risks and advantages of all major treatment options for patients with hyperthyroidism.
Source: Eurekalert
Can Drugs Affect Thyroid Function?
Some medications affect the normal function of thyroid gland leading to thyroid function disorders in the form of hypothyroidism or hyperthyroidism. Read Patient Information Leaflet of medications to be aware of such effects and conduct regular monitoring of thyroid function to avoid complications
Advertisement
 Goitre (Thyroid Swelling)Goitre is an enlargement of the thyroid gland. Autoimmune diseases, hereditary factors, iodine deficiency cause goitre. | Advertisement
|
Screening Tests for Thyroid Dysfunction
High or low thyroid stimulating hormone (TSH) level is indicative of a dysfunctional thyroid.
Advertisement
Recommended Readings
Latest Cancer News
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
The presence of painless swelling in the lymph nodes could potentially indicate lymphatic cancer, say experts.
